Advertisement

Cellceutix Corp. (OTCBB: CTIX) in Beverly announced Wednesday that it has research showing that its compound, Kevetrin, which is being developed to fight several drug-resistant cancers, may also be effective against brain tumors.

SOURCE

Advertisement
Advertisement